Age and the Residual Risk of Cardiovascular Disease following Low Density Lipoprotein-Cholesterol Exposure

Age and the Residual Risk of Cardiovascular Disease following Low Density Lipoprotein-Cholesterol Exposure

We believe that there is sufficient evidence from basic science, longitudinal cohort studies and randomised controlled trials which validates the low-density lipoprotein cholesterol (LDL-C) or lipid hypothesis. It is important that we can communicate details of the cardiovascular disease (CVD) risk...

Full description

Bibliographic Details
Main Authors:	Carola S. König, Amar Mann, Rob McFarlane, John Marriott, Malcolm Price, Sudarshan Ramachandran
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Biomedicines
Subjects:	mathematical modelling residual cardiovascular risk age and cardiovascular disease low density lipoprotein cholesterol exposure non-LDL-C cardiovascular risk factors
Online Access:	https://www.mdpi.com/2227-9059/11/12/3208

Similar Items

The Importance of Being Aware of Intrinsic Methods’ Limitation in Low-Density Lipoprotein Cholesterol Determination to Correctly Identify Cardiovascular Risk: Is Direct Determination Obtained with the Roche System Systematically Overestimating LDL in Very High-Risk Patients with Triglycerides Concentration of Less than 2.25 mmol/L?
by: Roberto Cemin, et al.
Published: (2023-06-01)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
by: Francesco Baratta, et al.
Published: (2023-02-01)

Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol
by: Pablo E. Gulayin, et al.
Published: (2022-10-01)

The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology
by: Salim S. Virani, et al.
Published: (2023-03-01)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01)

Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with ‘Normal’ LDL-C Levels
by: Harold Superko, et al.
Published: (2022-04-01)

Development of a Modified Friedewald’s Formula to Calculate Low-Density Lipoprotein in an Iranian Population
by: Seyed Alireza Sobhani, et al.
Published: (2023-09-01)

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
by: Junghyun Noh, et al.
Published: (2023-01-01)

Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?
by: Ulrich Julius, et al.
Published: (2020-07-01)

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations
by: Maureen Sampson, et al.
Published: (2022-12-01)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
by: Hilal Al-Sabti, et al.
Published: (2022-03-01)

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
by: Julius U
Published: (2016-10-01)

Low density lipoprotein cholesterol phenotypes and their association with risk factors of cardiovascular disease among subjects attending health screening at a public university in Malaysia
by: Mazalan, Norlianah
Published: (2019)

Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study
by: Bárbara Fernández-Cidón, et al.
Published: (2021-03-01)

Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements
by: Calvin Yeang, et al.
Published: (2021-01-01)

Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
by: Abdolreza Chary, et al.
Published: (2023-11-01)

Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis
by: Xianfeng Wu, et al.
Published: (2022-07-01)

A new phenotypic classification system for dyslipidemias based on the standard lipid panel
by: Maureen Sampson, et al.
Published: (2021-11-01)

High-density lipoprotein cholesterol: How High
by: G Rajagopal, et al.
Published: (2012-01-01)

Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
by: Chih-Sheng Chu, et al.
Published: (2020-07-01)

Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations
by: Pan X, et al.
Published: (2023-04-01)

Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population
by: Iokfai Cheang, et al.
Published: (2022-08-01)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
by: Hidekatsu Yanai, et al.
Published: (2022-11-01)

Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
by: Sang Heon Suh, et al.
Published: (2022-09-01)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
by: Allan D. Sniderman, et al.
Published: (2016-10-01)

Elevated high-density lipoprotein cholesterol and adverse outcomes in women with symptoms of ischemic heart disease
by: Sachini Ranasinghe, et al.
Published: (2024-04-01)

Higher triglyceride to high‐density lipoprotein cholesterol ratio increases cardiovascular risk: 10‐year prospective study in a cohort of Chinese adults
by: Zekai Chen, et al.
Published: (2020-03-01)

Exploring the Association between Low-Density Lipoprotein Subfractions and Major Adverse Cardiovascular Outcomes—A Comprehensive Review
by: Laura Adina Stanciulescu, et al.
Published: (2023-04-01)

Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study
by: Tae Kyung Yoo, et al.
Published: (2024-03-01)

The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis
by: Tong Lin, et al.
Published: (2020-03-01)

A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins
by: Ming Ding, et al.
Published: (2020-04-01)

High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
by: Chengfeng Qiu, et al.
Published: (2017-11-01)

Low density Lipoprotein cholesterol target: Changing goal posts
by: Ganapathi Bantwal, et al.
Published: (2012-01-01)

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
by: Shih-Wei Wang, et al.
Published: (2022-07-01)

Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study
by: Xiangming Hu, et al.
Published: (2020-07-01)

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies
by: Jelena Vekic, et al.
Published: (2022-01-01)

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study
by: Kausik K. Ray, et al.
Published: (2021-09-01)

Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins
by: Sarah Leatherman, et al.
Published: (2022-11-01)

What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines?
by: Madalina A. MUNTEANU, et al.
Published: (2019-12-01)

Accumulated exposure to high non-high-density lipoprotein cholesterol increases the risk of cardiovascular diseases in hypertensive individuals: An 11-year prospective cohort study
by: Weiqiang Wu, et al.
Published: (2023-12-01)